Clinical Trial Results: Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing N-acetylcysteine as antioxidant therapy in children with Neurofibromatosis Type 1 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Neurofibromatosis 1 | Phase 2 | Status: COMPLETED | Results posted: 2026-06-05